AVXL
Anavex Life Sciences Corp.
NASDAQ · Healthcare · Biotechnology · US
$2.86
+0.35%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-21.4%
Return on equity
-20.0%
Return on assets
-27.2%
Return on invested capital
0.00x
Asset turnover
-$33.7M
Cash from operations
$1.28
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026